These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 28342216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-desmogleins autoantibodies detected by ELISA and blotting in bullous pemphigoid: what do they mean?
    Julio T, Vernal S, Turatti A, Roselino AM.
    Int J Dermatol; 2018 Jan; 57(1):124-127. PubMed ID: 29152717
    [No Abstract] [Full Text] [Related]

  • 3. [Anti-desmoglein 1 and 3 antibody, anti-BP180(NC16a) antibody, anti-BP230 antibody].
    Amagai M.
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():614-7. PubMed ID: 20942145
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Desmoglein1 and BP 180 ELISA indexes correlating with disease activity in a patient with coexisting pemphigus foliaceus and bullous pemphigoid.
    Ando S, Sato-Matsumura KC, Kasai M, Nemoto-Hasebe I, Hoshina D, Ohyama B, Hashimoto T, Shimuzu H.
    Clin Exp Dermatol; 2009 Dec; 34(8):e995-6. PubMed ID: 20055881
    [No Abstract] [Full Text] [Related]

  • 6. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
    Maki N, Demitsu T, Umemoto N, Nagashima K, Nakamura T, Kakurai M, Nakamura S, Yamada T, Ishii N, Hashimoto T.
    J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
    [Abstract] [Full Text] [Related]

  • 7. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L, Deidda S, Aste N.
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [Abstract] [Full Text] [Related]

  • 8. Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.
    Andreadis D, Lorenzini G, Drakoulakos D, Belazi M, Mihailidou E, Velkos G, Mourellou-Tsatsou O, Antoniades D.
    Eur J Oral Sci; 2006 Oct; 114(5):374-80. PubMed ID: 17026501
    [Abstract] [Full Text] [Related]

  • 9. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.
    Fujio Y, Kojima K, Hashiguchi M, Wakui M, Murata M, Amagai M, Yamagami J.
    J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821
    [Abstract] [Full Text] [Related]

  • 10. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
    Cassano N, Mastrandrea V, Tampoia M, Filotico R, Vestita M, Vena GA.
    J Biol Regul Homeost Agents; 2009 Mar; 23(3):197-201. PubMed ID: 19828097
    [Abstract] [Full Text] [Related]

  • 11. A case of bullous pemphigoid with IgG antibodies against LAD-1, but not BP180 NC16a domain or BP230.
    Miyashita K, Iioka H, Miyagawa F, Ishii N, Hashimoto T, Asada H.
    Eur J Dermatol; 2018 Apr 01; 28(2):248-250. PubMed ID: 29378676
    [No Abstract] [Full Text] [Related]

  • 12. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
    Ono S, Tanioka M, Tanizaki H, Fujisawa A, Koga H, Hashimoto T, Kamiya K, Aoyama Y, Iwatsuki K, Miyachi Y.
    Br J Dermatol; 2013 Jun 01; 168(6):1357-60. PubMed ID: 23738642
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Zillikens D, Mascaro JM, Rose PA, Liu Z, Ewing SM, Caux F, Hoffmann RG, Diaz LA, Giudice GJ.
    J Invest Dermatol; 1997 Nov 01; 109(5):679-83. PubMed ID: 9347799
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V, Licarete E, Florea F, Cristea V, Popescu O, Sitaru C, Chiriac MT.
    Hum Immunol; 2014 Apr 01; 75(4):354-63. PubMed ID: 24468586
    [Abstract] [Full Text] [Related]

  • 17. Parallel fluctuation of anti-desmoglein 3 and anti-BP180 autoantibody titres in a patient with bullous pemphigoid.
    Takahashi H, Anzai H, Suzuki Y, Tanikawa A, Amagai M, Nishikawa T.
    Clin Exp Dermatol; 2004 Nov 01; 29(6):608-11. PubMed ID: 15550133
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Anti-p200 pemphigoid: a spectacular response to dapsone].
    Munsch C, Prey S, Joly P, Meyer N, Lamant L, Livideanu C, Viraben R, Paul C.
    Ann Dermatol Venereol; 2011 Nov 01; 138(11):739-42. PubMed ID: 22078034
    [Abstract] [Full Text] [Related]

  • 20. Two cases of childhood bullous pemphigoid.
    Toyama T, Nakamura K, Kuramochi A, Ohyama B, Hashimoto T, Tsuchida T.
    Eur J Dermatol; 2009 Nov 01; 19(4):368-71. PubMed ID: 19451055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.